People tend to negotiate with themselves when faced with difficult situations. I did that with the start of the Covid-19 pandemic.
For 24 years, this former banker quietly purchased small slices of the most expensive and top-selling drugs in the nation and became a billionaire.
Germany is taking a 23% stake in privately owned CureVac as it preps to push on with work for its mRNA vaccine against the COVID-19 pandemic.
After getting off a $46 million series A in 2018, Texas-based biotech Shattuck Labs has followed up with a major $118 million second funding round.
Verve Therapeutics launched last year with $58.5 million to create a one-and-done treatment to replace the array of drugs we use to treat heart disease. Now, it’s gearing up to move its ...
Proud of the past, rooted in the present and optimistic about the future By Geneviève Guertin & Didier Leconte Recently we proudly announced the creation of an important life ...
The Cambridge, Mass.-based company, which was officially launched in May 2019, is working on a treatment that would use gene-editing to lower cholesterol.
French Big Pharma Sanofi, looking to bolster its cancer R&D, has penned a new pact with Alphamab Oncology that focuses on HER2-positive breast cancer.